Molecular fingerprinting reflects different histotypes and brain region in low grade gliomas

BMC Cancer

Volumn 13, Issue , 2013, Pages 1-15

  Mascelli, Samantha ^a   Barla, Annalisa ^b   Raso, Alessandro ^a   Mosci, Sofia ^b   Nozza, Paolo ^a   Biassoni, Roberto ^a   Morana, Giovanni ^a   Huber, Martin ^c   Mircean, Cristian ^c   Fasulo, Daniel ^d   Noy, Karin ^d   Wittemberg, Gayle ^d   Pignatelli, Sara ^a   Piatelli, Gianluca ^a   Cama, Armando ^a   Garré, Maria L ^a   Capra, Valeria ^a   Verri, Alessandro ^b  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c SIEMENS AG   (Germany)

^d SIEMENS CORPORATE RESEARCH   (United States)

Author keywords

Gene expression profile; Low grade glioma; Machine learning; Mixed glial neuronal tumours; PA

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA; TRANSCRIPTOME;

ADOLESCENT; ARTICLE; CANCER GENETICS; CANCER GRADING; CELL GROWTH; CELL MOTILITY; CHILD; CLINICAL ARTICLE; DESMOPLASTIC INFANTILE GANGLIOGLIOMA; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION PROFILING; GENETIC ALGORITHM; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MACHINE LEARNING; MALE; MICROARRAY ANALYSIS; MIXED GLIAL NEURONAL TUMOR; MOLECULAR GENETICS; NERVOUS SYSTEM DEVELOPMENT; NUCLEOTIDE SEQUENCE; PILOCYTIC ASTROCYTOMA; PRIMARY TUMOR; SIGNAL TRANSDUCTION; VALIDATION PROCESS; ASTROCYTOMA; BRAIN TUMOR; CEREBELLUM TUMOR; CLUSTER ANALYSIS; GENE REGULATORY NETWORK; GENETICS; METABOLISM; METHODOLOGY; PATHOLOGY; PRESCHOOL CHILD; REPRODUCIBILITY;

ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GLIOMA; HUMANS; INFANT; INFRATENTORIAL NEOPLASMS; MALE; NEOPLASM GRADING; REPRODUCIBILITY OF RESULTS; SUPRATENTORIAL NEOPLASMS; TRANSCRIPTOME;

EID: 84883556394     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-387     Document Type: Article

References (55)

1. Sievert AJ, Fisher MJ. Pediatric low-grade gliomas. J Child Neurol 2009, 24(11):1397-1408.
2. Kaatsch P. Epidemiology of childhood cancer. Cancer Treat Rev 2010, 36:277-285.
3. Louis DOH, Wiestler O, Cavenee W. World Health Organization Classification of Tumors of the Central Nervous System 2007, Lyon: IARC 2007.
4. Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 2005, 64:479-489.
5. Pollack IF, Biegel J, Yates A, Hamilton R, Finkelstein S. Risk assignment in childhood brain tumors: the emerging role of molecular and biologic classification. Curr Oncol Rep 2002, 4:114-122.
6. Faria C, Miguéns J, Antunes JL, Salgado D, Nunes S, et al. Pediatric brain tumors: genetics and clinical outcome. J Neurosurg Pediatr 2010, 5:263-270.
7. Hargrave D. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy. Br J Neurosurg 2009, 23:351-363.
8. Qaddoumi I, Sultan I, Broniscer A. Pediatric low-grade gliomas and the need for new options for therapy: Why and how?. Cancer Biol Ther 2009, 8:4-10.
9. Sharma MK, Mansur DB, Reifenberger G, Perry A, Leonard JR, et al. Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin. Cancer Res 2007, 67:890-900.
10. Lee SH, Kim WT, Cornell-Bell AH, Sontheimer H. Astrocytes exhibit regional specificity in gap-junction coupling. Glia 1994, 11:315-325.
11. Ruzicka BB, Fox CA, Thompson RC, Meng F, Watson SJ, et al. Primary astroglial cultures derived from several rat brain regions differentially express mu, delta and kappa opioid receptor mRNA. Brain Res Mol Brain Res 1995, 34:209-220.
12. Ducray F, Marie Y, Sanson M. Idh1 and idh2 mutations in gliomas. N Engl J Med 2009, 360:2248-2249.
13. MacDonald TJ, Pollack IF, Okada H, Bhattacharya S, Lyons-Weiler J. Progression-associated genes in astrocytoma identified by novel microarray gene expression data reanalysis. Methods Mol Biol 2007, 377:203-222.
14. Dupuy A, Simon RM. Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting. J Natl Cancer Inst 2007, 99:147-157.
15. Ioannidis JPA. Why most published research findings are false. PLoS Med 2005, 2:e124.
16. Ioannidis JPA, Allison DB, Ball CA, Coulibaly I, Cui X, et al. Repeatability of published microarray gene expression analyses. Nat Genet 2009, 41:7.
17. Rickman DS, Tyagi R, Zhu XX, Bobek MP, Song S, et al. The gene for the axonal cell adhesion molecule tax-1 is amplified and aberrantly expressed in malignant gliomas. Cancer Res 2001, 61:2162-2168.
18. Shai R, Shi T, Kremen TJ, Horvath S, Liau LM, et al. Gene expression profiling identifies molecular subtypes of gliomas. Oncogene 2003, 22:4918-4923.
19. Wong KK, Chang YM, Tsang YTM, Perlaky L, Su J, et al. Expression analysis of juvenile pilocytic astrocytomas by oligonucleotide microarray reveals two potential subgroups. Cancer Res 2005, 65:76-84.
20. Rorive S, Maris C, Debeir O, Sandras F, Vidaud M, et al. Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles. J Neuropathol Exp Neurol 2006, 65:794-807.
21. Potter N, Karakoula A, Phipps KP, Harkness W, Hayward R, et al. Genomic deletions correlate with underexpression of novel candidate genes at six loci in pediatric pilocytic astrocytoma. Neoplasia (New York, NY) 2008, 10:757-772.
22. Marko NF, Prayson RA, Barnett GH, Weil RJ. Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study. Genomics 2010, 95:16-24.
23. Irizarry R, Bolstad B, Collin F, Cope L, Hobbs B, et al. Summaries of affymetrix genechip probe level data. Nucleic Acids Res 2003, 31:e15.
24. Destrero A, De Mol C, Odone F, Verri A. A sparsity-enforcing method for learning face features. IEEE Trans Image Process 2009, 18(1):188-201.
25. Bengtsson H, Simpson K, Bullard J, Hansen K. Aroma.affymetrix: A generic framework in R for analyzing small to very large Affymetrix data sets in bounded memory. Tech Report #745, Department of Statistics, University of California, Berkeley, February 2008.
26. Zou H, Hastie T. Regularization and variable selection via the elastic net. J ROY STAT SOC B 2005
27. Mol CD, Vito ED, Rosasco L. Elastic net regularization in learning theory. J Complex 2009
28. De Mol C, Mosci S, Traskine M, Verri A. A regularized method for selecting nested groups of relevant genes from microarray data. J Comput Biol 2009, 16:1-15.
29. Barla A, Mosci S, Rosasco L, Verri A. A method for robust variable selection with significance assessment. Proceedings of ESANN 2008
30. Fardin P, Barla A, Mosci S, Rosasco L, Verri A, et al. The l1-l2 regularization framework unmasks the hypoxia signature hidden in the transcriptome of a set of heterogeneous neuroblastoma cell lines. BMC Genomics 2009, 10:474.
31. Jurman G, Merler S, Barla A, Paoli S, Galea A, et al. Algebraic stability indicators for ranked lists in molecular profiling. Bioinformatics 2008, 24:258-264.
32. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using david bioinformatics resources. Nat Protoc 2009, 4:44-57.
33. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. Gene ontology: tool for the unification of biology. the gene ontology consortium. Nat Genet 2000, 25:25-9.
34. Hosack DA, Dennis G, Sherman BT, Lane HC, Lempicki RA. Identifying biological themes within lists of genes with ease. Genome Biol 2003, 4:R70.
35. Salomonis N, Hanspers K, Zambon AC, Vranizan K, Lawlor SC, et al. Genmapp 2: new features and resources for pathway analysis. BMC Bioinforma 2007, 8:217.
36. Kanehisa M, Goto S. Kegg: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000, 28:27-30.
37. BioCarta web site, the interactive web-based resources for life scientists http://www.biocarta.com.
38. Paquette J, Tokuyasu T. Egan: exploratory gene association networks. Bioinformatics 2010, 26:285-6.
39. Raso A, Mascelli S, Nozza P, Ugolotti E, Vanni I, et al. Troubleshooting fine-tuning procedures for qpcr system design. J Clin Lab Anal 2011, 25:389-94.
40. Raso A, Negri F, Gregorio A, Nozza P, Mascelli S, et al. Successful isolation and long-term establishment of a cell line with stem cell-like features from an anaplastic medulloblastoma. Neuropathol Appl Neurobiol 2008, 34:306-15.
41. Pfaffl MW. A new mathematical model for relative quantification in real-time rt-pcr. Nucleic Acids Res 2001, 29:e45.
42. Bustin SA. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000, 25:169-93.
43. Fiermonte G, Palmieri L, Todisco S, Agrimi G, Palmieri F, et al. Identification of the mitochondrial glutamate transporter. bacterial expression, reconstitution, functional characterization, and tissue distribution of two human isoforms. J Biol Chem 2002, 277:19289-94.
44. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, et al. The miqe guidelines: minimum information for publication of quantitative real-time pcr experiments. Clin Chem 2009, 55:611-22.
45. Hastie T, Tibshirani R, Friedman JH. The elements of statistical learning: data mining, inference, and prediction. Book 2009, 745.
46. Irizarry R, Wu Z, Jaffee H. Comparison of affymetrix genechip expression measures. Bioinformatics 2006, 22:789-94.
47. Stieber VW. Low-grade gliomas. Curr Treat Options Oncol 2001, 2(6):495-506.
48. Tatevossian RG, Lawson ARJ, Forshew T, Hindley GFL, Ellison DW, et al. Mapk pathway activation and the origins of pediatric low-grade astrocytomas. J Cell Physiol 2010, 222:509-14.
49. Martynoga B, Morrison H, Price DJ, Mason JO. Foxg1 is required for specification of ventral telencephalon and region-specific regulation of dorsal telencephalic precursor proliferation and apoptosis. Dev Biol 2005, 283:113-27.
50. Muzio L, Mallamaci A. Foxg1 confines cajal-retzius neuronogenesis and hippocampal morphogenesis to the dorsomedial pallium. J Neurosci 2005, 25:4435-41.
51. Hanashima C, Li SC, Shen L, Lai E, Fishell G. Foxg1 suppresses early cortical cell fate. Science 2004, 303:56-9.
52. Massagué J. Tgfbeta in cancer. Cell 2008, 134:215-30.
53. Yin XL, Hui ABY, Pang JCS, Poon WS, Ng HK. Genome-wide survey for chromosomal imbalances in ganglioglioma using comparative genomic hybridization. Cancer Genet Cytogenet 2002, 134:71-6.
54. Fukushima T, Katayama Y, Watanabe T, Yoshino A, Komine C, et al. Aberrant tp53 protein accumulation in the neuronal component of ganglioglioma. J Neurooncol 2005, 72:103-6.
55. Schindler G, Capper D, Meyer J, Janzarik W, Omran H, et al. Analysis of braf v600e mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 2011, 121:397-405.